Treatment of Excessive Bleeding in Jehovah's Witness Patients after Cardiac Surgery with Recombinant Factor VIIa (NovoSeven®)-Reference-Cited by-同舟云学术

Treatment of Excessive Bleeding in Jehovah's Witness Patients after Cardiac Surgery with Recombinant Factor VIIa (NovoSeven®)

Published:2003-06-01 Issue:6 Volume:98 Page:1513-1515
ISSN:0003-3022
Container-title:Anesthesiology
language:en
Short-container-title:

Author:

Tanaka Kenichi A.¹,Waly Amr A.²,Cooper William A.³,Levy Jerrold H.⁴

Affiliation:

1. Assistant Professor of Anesthesiology.

2. Cardiothoracic Anesthesia Fellow.

3. Assistant Professor of Surgery (Cardiothoracic).

4. Professor of Anesthesiology, Departments of Anesthesiology and Surgery (Cardiothoracic), Emory University School of Medicine and Division of Cardiothoracic Anesthesiology and Critical Care, Emory Healthcare, Atlanta, Georgia.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine

Link

http://pubs.asahq.org/anesthesiology/article-pdf/98/6/1513/407779/0000542-200306000-00034.pdf

Reference16 articles.

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Off-label Use of Recombinant Activated Factor VII for Cardiac Surgical Bleeding;Anesthesiology;2023-05-08

2. Factor eight inhibiting bypass activity for refractory bleeding in acute type A aortic dissection repair: A propensity‐matched analysis;Transfusion;2022-09-21

3. Review of abdominal solid organ transplantation in Jehovah’s Witness patients;World J Transplant;2019-09-16

4. The Utility of Thromboelastography to Guide Blood Product Transfusion;American Journal of Clinical Pathology;2019-07-02

5. Republication de : Situations critiques peropératoires chez le témoin de Jéhovah;Journal Européen des Urgences et de Réanimation;2018-12